REDWOOD CITY, Calif.,
Feb. 3, 2016 /PRNewswire/ -- Genomic
Health, Inc. (Nasdaq: GHDX) today announced that the
company will host a conference call and webcast on Wednesday,
February 10 at 4:30 p.m. Eastern Time to discuss its
fourth quarter and year-end 2015 financial results. The call and
webcast will follow the release of the fourth quarter and year-end
financial results after market close.
Conference Call Details
To access the live conference call on February
10 at 4:30 p.m. Eastern Time via phone, please dial
(877) 303-7208 from the United States and Canada, or
+1 (224) 357-2389 internationally. The conference call ID is
34365800. Please dial in approximately ten minutes prior to the
start of the call.
To access the live and subsequently archived webcast of the
presentation, go to the Investor Relations section of the company's
web site at http://investor.genomichealth.com. Please connect to
the web site at least 15 minutes prior to the presentation to allow
for any software download that may be necessary.
About Genomic Health
Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider
of genomic-based diagnostic tests that address both the
overtreatment and optimal treatment of early-stage cancer, one of
the greatest issues in healthcare today. The company is applying
its world-class scientific and commercial expertise and
infrastructure to lead the translation of massive amounts of
genomic data into clinically-actionable results for treatment
planning throughout the cancer patient's journey, from diagnosis to
treatment selection and monitoring. The company is based
in Redwood City, California, with international
headquarters in Geneva, Switzerland. For more
information, please visit, www.GenomicHealth.com and
follow the company on
Twitter: @GenomicHealth, Facebook, YouTube and LinkedIn.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
and the other risks set forth in the company's filings with
the Securities and Exchange Commission, including the risks
set forth in the company's quarterly report on Form 10-Q for the
quarter ended September 30, 2015. These forward-looking
statements speak only as of the date hereof. Genomic
Health disclaims any obligation to update these
forward-looking statements.
NOTE: The Genomic Health logo, Oncotype, Oncotype
DX, Recurrence Score, and DCIS Score are trademarks or registered
trademarks of Genomic Health, Inc. All other trademarks
and service marks are the property of their respective
owners.
Logo -
http://photos.prnewswire.com/prnh/20130425/SF01493LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/genomic-health-to-announce-fourth-quarter-and-year-end-2015-financial-results-and-host-conference-call-on-wednesday-february-10-2016-300214237.html
SOURCE Genomic Health, Inc.